borderline significantp = 0.05
There was borderline significant directional selection for Pfmdr1 184F in recurrent malaria infections after treatment with AL in Uganda site (p = 0.05).
There was borderline significant directional selection for Pfmdr1 184F in recurrent malaria infections after treatment with AL in Uganda site (p = 0.05).
However, on both sites, there was no evidence of drug-mediated selection in either phase except the observed borderline directional selection for Pfmdr1 184F and borderline significance for Pfmdr1 N86 in recurrent infections after AL treatment ( Table 3 ).